Andrew Cheng, President and CEO at Akero Therapeutics, Inc. (AKRO), sold 13,240 shares at $54.84 ($726K) on 2025-06-18, disclosed to the SEC on 2025-06-20.
Open-market sale of $726k AKRO by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $54.84 | 6,620 | $363K | 50.0% |
| 2 | $54.84 | 6,620 | $363K | 50.0% |
| Total | $54.84 avg | 13,240 | $726K | 100% |
| Filing → |
| AKRO | SELL | 2025-08-13 | $2.9M | — | Filing → |
| AKRO | SELL | 2025-07-11 | $3.1M | — | Filing → |
| AKRO | SELL | 2025-06-12 | $4.1M | — | Filing → |